Vanguard Personalized Indexing Management LLC Buys Shares of 4,064 National Health Investors, Inc. (NYSE:NHI)

Vanguard Personalized Indexing Management LLC bought a new stake in National Health Investors, Inc. (NYSE:NHI) in the second quarter, HoldingsChannel reports. The fund bought 4,064 shares of the real estate investment trust’s stock, valued at approximately $275,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in National Health Investors by 0.7% in the first quarter. Vanguard Group Inc. now owns 6,189,864 shares of the real estate investment trust’s stock valued at $388,909,000 after acquiring an additional 43,520 shares during the period. Lasalle Investment Management Securities LLC grew its stake in National Health Investors by 8.4% in the first quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust’s stock valued at $31,920,000 after acquiring an additional 39,554 shares during the period. Sumitomo Mitsui Trust Holdings Inc. grew its stake in National Health Investors by 16.0% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock valued at $32,034,000 after acquiring an additional 65,104 shares during the period. Norges Bank acquired a new position in shares of National Health Investors during the fourth quarter worth about $25,448,000. Finally, Land & Buildings Investment Management LLC boosted its position in shares of National Health Investors by 81.8% during the fourth quarter. Land & Buildings Investment Management LLC now owns 412,052 shares of the real estate investment trust’s stock worth $23,013,000 after buying an additional 185,377 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Stock Performance

NHI opened at $82.99 on Monday. National Health Investors, Inc. has a 52-week low of $48.51 and a 52-week high of $86.13. The firm has a market capitalization of $3.60 billion, a PE ratio of 27.21, a PEG ratio of 8.86 and a beta of 1.04. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27. The business’s 50-day simple moving average is $78.82 and its 200 day simple moving average is $69.78.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The company had revenue of $84.97 million for the quarter, compared to the consensus estimate of $64.95 million. During the same quarter in the previous year, the company posted $1.06 EPS. The business’s revenue was up 9.1% on a year-over-year basis. As a group, sell-side analysts expect that National Health Investors, Inc. will post 4.55 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be issued a dividend of $0.90 per share. The ex-dividend date is Friday, September 27th. This represents a $3.60 annualized dividend and a yield of 4.34%. National Health Investors’s payout ratio is presently 118.03%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on NHI. StockNews.com raised National Health Investors from a “hold” rating to a “buy” rating in a research report on Thursday, August 8th. Truist Financial upped their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Finally, Bank of America began coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $70.86.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.